Humira, Advair, Rituxan top list of 2012 best-selling drugs worldwide

03/6/2013 | Genetic Engineering & Biotechnology News

AbbVie's Humira, or adalimumab, topped this list of last year's 20 best-selling drugs worldwide, based on publicly available figures. GlaxoSmithKline's Advair came in second, followed by Roche Holding's Rituxan, or rituximab. Rounding out the top 10 were Sanofi's Lantus, Roche's Herceptin, AstraZeneca's Crestor, Johnson & Johnson's Remicade, Roche's Avastin, Eli Lilly and Co.'s Cymbalta, and Sanofi and Bristol-Myers Squibb's Plavix.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care